ACSMA is campaigning to give greater choice to patients on long term warfarin and change the lives of thousands of patients. Pledge your support to make this change a reality.
ACSMA comprises some of the UK’s leading charities and patient groups – including AntiCoagulation Europe; AF Association – that exist to provide advice, support and guidance to people on oral anticoagulation therapy, as well as their families and healthcare professionals. Healthcare company Roche is also part of the alliance.
About AntiCoagulation Europe (ACE)
AntiCoagulation Europe (ACE) is a registered charity committed to the prevention of thrombosis and the provision of inf0ormation and support for people receiving anticoagulant and antiplatelet therapy. For more information, please go to the website: www.anticoagulationeurope.org/
About AF Association
AF Association is an international charity which provides information, support and access to established, new or innovative treatments for Atrial Fibrillation (AF). For more information, please go to the website: www.atrialfibrillation.org.uk/
Headquartered in Basel, Switzerland, Roche is a leader in research-focused healthcare with combined strengths in pharmaceuticals and diagnostics. Roche is the world’s largest biotech company with truly differentiated medicines in oncology, virology, inflammation, metabolism and CNS. Roche is also the world leader in in-vitro diagnostics, tissue-based cancer diagnostics and a pioneer in diabetes management. Roche’s personalized healthcare strategy aims at providing medicines and diagnostic tools that enable tangible improvements in the health, quality of life and survival of patients. In 2011, Roche had over 80,000 employees worldwide and invested over 8 billion Swiss francs in R&D. The Group posted sales of 42.5 billion Swiss francs. Genentech, United States, is a wholly owned member of the Roche Group. Roche has a majority stake in Chugai Pharmaceutical, Japan. For more information visit: www.roche.com and www.roche.co.uk